Organon sees FY26 revenue $6.2B, consensus $6.11B

Sees FY26 adjusted EBITDA $1.9B. Sees FY26 tax rate 27.5%-29.5%. The company said, “For full year 2026, the company expects to achieve revenue of approximately $6.2 billion and Adjusted EBITDA of approximately $1.9 billion; both measures in-line with 2025 performance. The company expects that the annual revenue foregone with the sale of the JADA system will be approximately offset by favorable currency translation, resulting in constant currency revenue growth about flat with prior year, pro forma for the JADA system divestiture.”